Meghan Scanlon - 24 Jun 2021 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: SVP,Pres,Urology Pelvic Health
Signature: /s/ Vance R. Brown, Attorney-in-fact
Issuer symbol: BSX
Transactions as of: 24 Jun 2021
Net transactions value: -$440,366
Form type: 4
Filing time: 28 Jun 2021, 16:18:30 UTC
Next filing: 06 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$283,927	+16,450	+92%	$17.26	34,280	24 Jun 2021	Direct	F1
transaction	BSX	Common Stock	Sale	$724,294	-16,450	-48%	$44.03	17,830	24 Jun 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Stock Option (Right to Buy)	Options Exercise	$0	-16,450	-100%	$0.000000^*	0	24 Jun 2021	Common Stock	16,450	$17.26	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2	Grant to the reporting person of an option to purchase 18,450 shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.